MEDNAX Makes 10

MEDNAX (NYSE:MD) hit the big 10 in August 2016, with its tenth acquisition of the year. The serial acquirer picked up privately-held Associated Anesthesiologists of Reno, P.C., the largest anesthesia practice in northern Nevada, offering anesthesia care across a broad range of subspecialties, including orthopedic, obstetric, pediatric and cardiac and critical care. MEDNAX continues to capitalize on anesthesiology practices’ need to become a part of a larger organization in order to meet the data and technology capabilities that hospitals are asking of them, and this purchase marks its sixth anesthesiology acquisition of the year. Outside of anesthesiology, MEDNAX acquired privately-held... Read More »

Home Health’s Hot Summer Streak

With 38 deals so far in 2016, home health care continues to be a hot topic. Three deals were announced in the first week of August alone, with Dallas-based Epic Health Services being the acquirer for two of these deals. Epic Health Services, a portfolio company of Webster Capital, provides pediatric skilled nursing, therapy, developmental, enteral and respiratory services. On August 1st, the company announced the acquisition of Pediatric Special Care Inc., the only pediatric nursing and home medical equipment company in Michigan. It offers private-duty nursing services and a full range of high-tech medical equipment. Three days later, Epic Health acquired privately-held Spring View Home... Read More »

Cantel Medical Adds Dental to Its Healthcare Disposables Segment

With five acquisitions in the infection prevention/disposables market since 2014, Cantel Medical (NYSE: CMN) is on a roll. The company, which provides infection prevention and control product and services, just announced its second medical device deal this year, buying Accutron Inc., a privately-held manufacturer of nitrous oxide delivery systems and single-use nasal masks. The $52.5 million acquisition will expand the dental portfolio of Crosstex International, Cantel’s Healthcare Disposables segment, adding a branded, single-use disposable product line. The acquisition marks Cantel’s entry into the dental equipment market. In February 2016, Cantel acquired the Sterility... Read More »

Pfizer Buys into Gene Therapy

Pfizer’s (NYSE: PFE) interest in the field of gene therapy just got real. The pharma giant just spent $193 million to pick up Bamboo Therapeutics Inc., a privately-held biotechnology company that focuses on therapies for rare and devastating central nervous system (CNS) and neuromuscular diseases. In the first quarter of 2016, Pfizer acquired 22% of Bamboo’s fully diluted equity for $43 million. On August 2, the company announced that it had acquired the remaining equity for an upfront payment of $150 million. Bamboo Therapeutics is also eligible to receive milestone payments of up to $495 million. Since 2014, Pfizer has established gene therapy-based collaborations, research and... Read More »